Source Statements — No Public Why FoundManagement is quoted · no explanatory analyst or media source was found
Analyst question
Analyst · earnings call
“First, on Medicaid, you had talked up to -1.1% to -1.7% margin previously. Curious, sounds like you’re seeing some improvement there. Maybe you can give us some color on what you expect the year to end up. And then on commercial, can you talk about the magnitude of the cost trend pressure you’re seeing here versus that 11% expectations and maybe update us on how we should think about commercial margins this year and the trajectory versus the previous assumption?”
Analyst question
Analyst · earnings call
“Do you feel like you’re going to do obviously better than that this year?”
Sourced Takeaways5 takeaways · every bullet sourced
Revenue was $112.0B; versus $111.6B a year earlier; +0.4% YoY.
Filed8-K 2026-07-16 · P.4
Medical care ratio was 86.7%; versus 89.4% a year earlier; -2.7pp YoY.
Filed8-K 2026-07-16 · P.4
Adjusted EPS was $6.38; versus $4.08 a year earlier; +56.4% YoY.
Filed8-K 2026-07-16 · P.16
Diluted EPS (GAAP) was $6.04; versus $3.74 a year earlier; +61.5% YoY.
Filed8-K 2026-07-16 · P.9
Earnings from operations was $8.0B; versus $5.2B a year earlier; +55.2% YoY.
Filed8-K 2026-07-16 · P.4
The NumbersReported · published precision · every figure sourced
| Metric | Q2 2026 | Prior yr | YoY | FY Guide |
| Revenue | $112.0B | $111.6B | +0.4% | — |
| Medical care ratio incl. $860M PPD | 86.7% | 89.4% | -2.7pp | — |
| Adjusted EPS beat ~$4.91 cons. | $6.38 | $4.08 | +56.4% | — |
| Diluted EPS (GAAP) | $6.04 | $3.74 | +61.5% | — |
| Earnings from operations | $8.0B | $5.2B | +55.2% | — |
| Operating cost ratio | 12.7% | 12.3% | +0.4pp | — |
| Medicare Advantage members -965K since YE25 | 7.57M | 8.35M | -9.4% | — |
| Medicare & Retirement revenue | $42.4B | $42.6B | -0.5% | — |
| FY26 medical care ratio guide 88.8% ±50bp at Jan 27; Q1 did not restate | 88.1% | 88.8% | -0.7pp | 88.1% ±25bp |
| FY26 GAAP EPS guide Jan 27 baseline >$17.10 | $18.45–$18.95 | >$17.35 | — | Raised |
| FY26 adjusted EPS guide Jan 27 baseline was >$17.75 | $19.50–$20.00 | >$18.25 | — | Raised |
Guidance Language DeltaQ1 2026 outlook (Apr 21) → Q2 2026 outlook (Jul 16)
Q1 2026 outlook (Apr 21)
Full year 2026 adjusted net earnings of greater than $18.25 per share, and diluted net earnings of greater than $17.35 per share. The Q1 release did not restate a medical care ratio band.
UNH Q1 2026 earnings release, Apr 21 2026 · p.1 and p.16 (Form 8-K dated 2026-04-21)
Q2 2026 outlook (Jul 16)
Adjusted earnings per share of $19.50 to $20.00 and diluted earnings per share of $18.45 to $18.95, with a medical care ratio of 88.1% plus or minus 25 basis points.
UNH Q2 2026 earnings release, Jul 16 2026 · p.1 and p.6 outlook table (Form 8-K dated 2026-07-16)
Initial FY 2026 outlook, set Jan 27, 2026Adjusted earnings per share of greater than $17.75, with a medical care ratio of 88.8% plus or minus 50 basis points.
UNH Q2 2026 earnings release, Jul 16 2026 · p.6 outlook table, column 'As of January 27, 2026'
Thread Postings3 threads advanced
The DocumentsEverything this record is built from
Full call, speaker-attributed, auto-segmented from the third-party feed with Tally's margin notes. UNH publishes no Q&A transcript on its own IR site, so this is the only place to read the exchanges.
70 turns
The reported numbers at published precision. MCR and the $860M development on p.4; segment and membership detail p.5, p.14.
17 PP.
People served by line. Medicare Advantage 7.565M — the source for the -9.4% YoY and -965K since year-end.
P.14
Reserve roll-forward to size the prior-period development, plus DOJ investigation disclosure. Files within days of the call.
PENDING
Ground-truth MA enrollment by county — the WS1 join to confirm where the 965K exits landed and who is absorbing them.
PENDING